BR1100240A - Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto - Google Patents

Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto

Info

Publication number
BR1100240A
BR1100240A BR1100240-9A BR1100240A BR1100240A BR 1100240 A BR1100240 A BR 1100240A BR 1100240 A BR1100240 A BR 1100240A BR 1100240 A BR1100240 A BR 1100240A
Authority
BR
Brazil
Prior art keywords
compound
preparing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR1100240-9A
Other languages
English (en)
Inventor
Franco Buzzetti
Natale Barbugian
Paolo Lombardi
Enrico Di Salle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10582036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100240(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR1100240A publication Critical patent/BR1100240A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR1100240-9A 1985-07-09 1997-04-08 Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto BR1100240A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517360A GB8517360D0 (en) 1985-07-09 1985-07-09 Substituted androsta-1,4-diene-3,17-diones

Publications (1)

Publication Number Publication Date
BR1100240A true BR1100240A (pt) 1999-12-28

Family

ID=10582036

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100240-9A BR1100240A (pt) 1985-07-09 1997-04-08 Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto

Country Status (38)

Country Link
US (2) US4808616A (pt)
JP (1) JPS6212797A (pt)
KR (1) KR950003614B1 (pt)
CN (1) CN86104664B (pt)
AT (1) AT395157B (pt)
AU (1) AU578840B2 (pt)
BE (1) BE905067A (pt)
BG (1) BG61370B2 (pt)
BR (1) BR1100240A (pt)
CA (1) CA1277656C (pt)
CH (1) CH668599A5 (pt)
CS (2) CS257794B2 (pt)
CZ (1) CZ413591A3 (pt)
DE (1) DE10199030I1 (pt)
DK (1) DK163520C (pt)
ES (2) ES8801304A1 (pt)
FI (1) FI83424C (pt)
FR (1) FR2584725B1 (pt)
GB (2) GB8517360D0 (pt)
GR (1) GR861780B (pt)
HK (1) HK94190A (pt)
HU (1) HU194274B (pt)
IE (1) IE58949B1 (pt)
IL (1) IL79336A (pt)
IT (1) IT1196436B (pt)
MY (1) MY102294A (pt)
NL (2) NL193616C (pt)
NO (2) NO165547C (pt)
NZ (1) NZ216763A (pt)
PH (1) PH21785A (pt)
PT (1) PT82944B (pt)
SE (1) SE468988B (pt)
SG (1) SG80490G (pt)
SK (1) SK413591A3 (pt)
SU (2) SU1442077A3 (pt)
UA (1) UA6046A1 (pt)
YU (2) YU44585B (pt)
ZA (1) ZA865079B (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
EP0582713B1 (en) * 1991-03-28 1997-06-04 Teikoku Hormone Mfg. Co., Ltd. -New D-homo-17-oxa and D-homo-17-aza-androstane derivatives
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
NZ256130A (en) * 1992-09-30 1996-05-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid derivatives; pharmaceutical compositions
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
AU5873300A (en) * 1999-07-07 2001-01-30 Pharmacia & Upjohn Company Process to prepare exemestane
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia
GB0005257D0 (en) * 2000-03-03 2000-04-26 Pharmacia & Upjohn Spa Breast cancer hormonal therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0017635D0 (en) * 2000-07-18 2000-09-06 Pharmacia & Upjohn Spa Antitumor combined therapy
AU2001283964A1 (en) * 2000-08-09 2002-02-18 Pharmacia And Upjohn Company Composition for combined use of aromatase inhibitors
US20040024044A1 (en) * 2000-09-08 2004-02-05 Di Salle Enrico Exemestane as chemopreventing agent
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
CA2434611A1 (en) * 2001-01-26 2002-09-19 Pharmacia Italia Spa Combined method for treating hormono-dependent disorders
EP2269603B1 (en) 2001-02-19 2015-05-20 Novartis AG Treatment of breast tumors with a rapamycin derivative in combination with exemestane
PL392652A1 (pl) 2001-05-16 2010-12-06 Novartis Ag Kombinacja zawierająca N-{5-[4-(4-metylo-piperazyno-metylo)-benzoiloamido]-2-metylofenylo}-4-(3-pirydylo)-2-pirymidyno-aminę oraz środek chemoterapeutyczny, jej zastosowanie, kompozycja farmaceutyczna ją zawierająca oraz zestaw zawierający taką kombinację
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
US20040043938A1 (en) * 2001-11-06 2004-03-04 Dinesh Purandare Combination therapy for estrogen-dependent disorders
GB0128510D0 (en) * 2001-11-28 2002-01-23 Novartis Ag Organic compounds
CN1652757B (zh) 2002-05-16 2012-02-08 诺瓦提斯公司 Edg受体结合剂在癌症中的应用
CN1304413C (zh) * 2002-10-24 2007-03-14 上海华拓医药科技发展有限公司 一种抗癌药物依西美坦制备方法
CN1317293C (zh) * 2002-10-24 2007-05-23 南京长澳医药科技有限公司 一种依西美坦的合成工艺
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
US8183401B2 (en) * 2004-01-16 2012-05-22 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
JP5255444B2 (ja) 2005-09-30 2013-08-07 エンディース エルエルシー （ｓ）−６−メチルオキサアルキルエキセメスタン化合物および関連する使用方法
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
BRPI0711385A2 (pt) 2006-05-09 2011-11-08 Novartis Ag combinação compreendendo um quelante de ferro e um agente anti-neoplástico e seu uso
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
JP5558358B2 (ja) 2007-10-16 2014-07-23 レプロス セラピューティクス インコーポレイティド メタボリック症候群用のｔｒａｎｓ−クロミフェン
EP2070943A1 (en) * 2007-12-14 2009-06-17 Crystal Pharma, S.A. Process for obtaining 6-Alkylidenandrost-1,4-diene-3one
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
WO2009093262A2 (en) * 2008-01-21 2009-07-30 Cadila Healthcare Limited Process for preparing aromatase inhibitor exemestane
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
WO2010076811A2 (en) * 2008-12-30 2010-07-08 Ind-Swift Laboratories Limited Process for the preparation of exemestane
EP2429299B1 (en) 2009-05-01 2016-06-01 Celloxess Llc Treating male infertility secondary to sperm oxidative stress
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
JP2013525296A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー 内分泌療法抵抗性乳癌の処置
SG188396A1 (en) 2010-09-14 2013-04-30 Endece Llc 6-substituted demethyl-estradiol derivatives as er-beta agonists
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
KR20160110963A (ko) 2014-02-11 2016-09-23 노파르티스 아게 암 치료를 위한 pi3k 억제제를 포함하는 제약 조합물
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (pt) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US3112305A (en) * 1960-11-07 1963-11-26 British Drug Houses Ltd 6-methylene-3-oxo-delta4-steroids and process for their preparation
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
BE759143A (fr) * 1969-11-19 1971-05-19 Upjohn Co Procede de preparation d'un nouveau compose steroide
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
YU120186A (en) 1988-02-29
IE861821L (en) 1987-01-09
GB2177700B (en) 1988-12-07
GR861780B (en) 1986-11-11
NO165547C (no) 1991-02-27
ES556550A0 (es) 1987-12-16
FR2584725A1 (fr) 1987-01-16
IL79336A (en) 1991-06-10
HK94190A (en) 1990-11-23
FI862871A0 (fi) 1986-07-07
UA6046A1 (uk) 1994-12-29
NO862753L (no) 1987-01-12
PH21785A (en) 1988-02-24
YU44585B (en) 1990-10-31
SE8603046L (sv) 1987-01-10
IT8621004A0 (it) 1986-07-02
NZ216763A (en) 1988-05-30
DK163520C (da) 1992-07-27
HUT42780A (en) 1987-08-28
FI83424C (fi) 1991-07-10
FR2584725B1 (fr) 1988-05-13
GB8616585D0 (en) 1986-08-13
CZ413591A3 (en) 1994-03-16
SU1501923A3 (ru) 1989-08-15
JPS6212797A (ja) 1987-01-21
NO2000009I1 (no) 2000-10-05
ES8802429A1 (es) 1988-06-01
US4904650A (en) 1990-02-27
YU103687A (en) 1988-08-31
YU44628B (en) 1990-10-31
PT82944B (pt) 1989-01-30
NO862753D0 (no) 1986-07-08
BG61370B2 (bg) 1997-06-30
DE10199030I1 (de) 2001-10-04
ATA181986A (de) 1992-02-15
NL193616C (nl) 2000-04-04
JPH0443919B2 (pt) 1992-07-20
SK413591A3 (en) 1995-07-11
IT1196436B (it) 1988-11-16
MY102294A (en) 1992-05-15
NL300017I1 (nl) 2000-11-01
AU5979986A (en) 1987-01-15
GB8517360D0 (en) 1985-08-14
ZA865079B (en) 1987-03-25
ES8801304A1 (es) 1987-12-16
NL300017I2 (nl) 2001-01-02
CN86104664A (zh) 1987-02-18
SU1442077A3 (ru) 1988-11-30
AT395157B (de) 1992-10-12
NL8601785A (nl) 1987-02-02
US4808616A (en) 1989-02-28
DK324386D0 (da) 1986-07-08
ES557466A0 (es) 1988-06-01
FI83424B (fi) 1991-03-28
DK163520B (da) 1992-03-09
FI862871A (fi) 1987-01-10
SE468988B (sv) 1993-04-26
CS258498B2 (en) 1988-08-16
BE905067A (fr) 1987-01-08
CA1277656C (en) 1990-12-11
GB2177700A (en) 1987-01-28
KR870001140A (ko) 1987-03-11
NL193616B (nl) 1999-12-01
SE8603046D0 (sv) 1986-07-08
PT82944A (en) 1986-08-01
HU194274B (en) 1988-01-28
IL79336A0 (en) 1986-10-31
CN86104664B (zh) 1988-06-29
KR950003614B1 (ko) 1995-04-17
IE58949B1 (en) 1993-12-01
AU578840B2 (en) 1988-11-03
CH668599A5 (de) 1989-01-13
CS521486A2 (en) 1987-09-17
DK324386A (da) 1987-01-10
SG80490G (en) 1990-11-23
NO165547B (no) 1990-11-19
CS257794B2 (en) 1988-06-15

Similar Documents

Publication Publication Date Title
BR1100240A (pt) Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
PT83876B (pt) Processo para a preparacao de derivados de butiramida n-substituidos
BR8605596A (pt) Processo para a preparacao de composicoes e para a preparacao de compostos
PT83179B (pt) Processo para a preparacao de carbinois aril-piperidinicos
PT83152B (pt) Processo para a preparacao de compostos di-t-butilfenoicos
PT83835B (pt) Processo para a preparacao de novos derivados de calcitonina
PT82062B (pt) Processo para a preparacao de compostos piridinilimidazolidinona
BR8601962A (pt) Processo para a preparacao de compostos
PT81531B (pt) Processo para a preparacao de silibinina isenta de isosilibina e de composicoes farmaceuticas contendo silibinina
BR8702278A (pt) Processo para a preparacao de um composto e composicao
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT81605B (pt) Processo para a preparacao de derivados de imidazolilalquil-guanidina e de composicoes farmaceuticas contendo estes compostos
PT82678B (pt) Processo para a preparacao de compostos de cinolina
PT89616A (pt) Processo para a preparacao de composicoes artropodicidas contendo misturas sinergicas de derivados piretroides e butoxido de piperonilo
PT82383B (pt) Processo para a preparacao de epipodofilotoxina e compostos afins
BR8704361A (pt) Composicao explosiva e processo para a preparacao de um explosivo
PT82585B (pt) Processo para a preparacao de composicoes funcigidas e algicidas contendo derivados de piridazinio
PT82167B (pt) Processo para a preparacao de sulfureto heterociclicos e de composicoes farmceuticas que os contem
BR8706851A (pt) Processo para a preparacao de um composto e processo para colorir material
PT83305B (pt) Processo para a preparacao de derivados de xantina e de composicoes farmaceuticas que os contem
PT82464B (pt) Processo para a preparacao de novos derivados de benzisoselenazolonilo e de composicoes farmaceuticas que os contem
BR8606154A (pt) Processo para a preparacao de compostos glicidilicos e emprego

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
B25A Requested transfer of rights approved

Free format text: PHARMACIA ITALIA S.P.A. (IT)